SLC41A3

Across TCGA pan-cancer cohorts, SLC41A3 mass-spec protein differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of SLC41A3’s most consistent transcriptional readouts.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where SLC41A3 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types SLC41A3 is over-expressed in tumor, although a few such as HNSC and LSCC show the opposite, repressed pattern.

HNSC, LSCC, and CCRCC are the cancer types where SLC41A3 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in SLC41A3 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
HNSC	All	II,III,IV	−0.260	<.001	11	view →
LSCC	Male	All	−0.365	<.001	6	view →
CCRCC	Male	II,III,IV	−0.307	<.001	6	view →
COAD	Male	All	−0.500	.039	3	view →
LUAD	All	All	−0.175	.001	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

SLC41A3–HNSC

Open the HNSC breakdown →